Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load
- PMID: 12441804
- DOI: 10.1097/00002030-200211220-00012
Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load
Abstract
Background: Virus-specific cellular immune responses mediated by CD4 and CD8 T lymphocytes are thought to be central to the effective control of HIV-1 replication in vivo. However, quantitative correlations between HIV-specific T lymphocyte frequencies and plasma virus load (pVL) have proved difficult to establish in infected human individuals. This most likely reflects the complex interactions between the virus and these immune effector cells in the absence of treatment.
Objective: To assess frequencies of HIV-specific T lymphocytes after prolonged suppression of viral replication, i.e., under conditions where the effects of virus on the immune response are standardized and minimized, thereby fixing an important variable in a dynamic multivariate system.
Methods: HIV-specific CD4 and CD8 T lymphocyte frequencies were measured in 122 individuals after prolonged periods of successful combination antiretroviral therapy (ART) administered during chronic HIV-1 infection.
Results: The residual frequency of both CD4 and CD8 T lymphocytes specific for HIV-1 was inversely related to the pretreatment pVL. This relationship appeared to be non-linear, indicating the presence of a threshold pretreatment pVL level above which HIV-specific CD4 and CD8 T lymphocyte responses could not be maintained when antigenic drive was suppressed. Substantial populations of functional HIV-specific CD4 and CD8 T lymphocytes were generally detectable after prolonged ART only in those individuals with a pretreatment plasma HIV-1 RNA < 100,000 copies/ml.
Conclusion: These findings identify a quantitative immune associate of host-virus interactions in established HIV-1 infection.
Copyright 2002 Lippincott Williams & Wilkins
Similar articles
-
Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.J Virol. 2003 May;77(10):6041-9. doi: 10.1128/jvi.77.10.6041-6049.2003. J Virol. 2003. PMID: 12719595 Free PMC article. Clinical Trial.
-
Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load.J Clin Immunol. 2002 Nov;22(6):363-74. doi: 10.1023/a:1020656300027. J Clin Immunol. 2002. PMID: 12462336
-
Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13747-52. doi: 10.1073/pnas.202372199. Epub 2002 Oct 7. Proc Natl Acad Sci U S A. 2002. PMID: 12370434 Free PMC article. Clinical Trial.
-
Harnessing CD8+ T Cells Under HIV Antiretroviral Therapy.Front Immunol. 2019 Feb 26;10:291. doi: 10.3389/fimmu.2019.00291. eCollection 2019. Front Immunol. 2019. PMID: 30863403 Free PMC article. Review.
-
Perspectives on inducing efficient immune control of HIV-1 replication--a new goal for HIV therapeutics?AIDS. 2001 Feb;15 Suppl 2:S36-42. doi: 10.1097/00002030-200102002-00007. AIDS. 2001. PMID: 11424975 Review.
Cited by
-
Do HIV-specific CTL continue to have an antiviral function during antiretroviral therapy? If not, why not, and what can be done about it?Front Immunol. 2013 Mar 1;4:52. doi: 10.3389/fimmu.2013.00052. eCollection 2013. Front Immunol. 2013. PMID: 23459829 Free PMC article.
-
Killing of Latently HIV-Infected CD4 T Cells by Autologous CD8 T Cells Is Modulated by Nef.Front Immunol. 2018 Sep 11;9:2068. doi: 10.3389/fimmu.2018.02068. eCollection 2018. Front Immunol. 2018. PMID: 30254642 Free PMC article.
-
Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions.J Virol. 2005 Jul;79(14):9026-37. doi: 10.1128/JVI.79.14.9026-9037.2005. J Virol. 2005. PMID: 15994796 Free PMC article.
-
Human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cells that proliferate in vitro detected in samples from most viremic subjects and inversely associated with plasma HIV-1 levels.J Virol. 2004 Nov;78(22):12638-46. doi: 10.1128/JVI.78.22.12638-12646.2004. J Virol. 2004. PMID: 15507650 Free PMC article.
-
CD4+ T cell targeting of human immunodeficiency virus type 1 (HIV-1) peptide sequences present in vivo during chronic, progressive HIV-1 disease.Virology. 2007 Apr 25;361(1):34-44. doi: 10.1016/j.virol.2006.10.040. Epub 2006 Dec 13. Virology. 2007. PMID: 17169395 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials